Savanna Biotherapeutics, Inc. — Form D
Savanna Biotherapeutics, Inc. of ALISO VIEJO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-11-18. The offering totals $54.3M, of which $24.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-11-18
- Form: D
- Accession: 0001873404-22-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $54.3M
- Amount sold: $24.3M
- Remaining: $30.0M
- Investors: 54
- Date of first sale: 2022-11-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-465212
Issuer
- Name: Savanna Biotherapeutics, Inc.
- CIK: 0001873404
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: C/O UNIVERSITY LAB PARTNERS, CURIE HALL, ALISO VIEJO, CA, 92656
- Phone: 716-969-2573
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Michael L Speiser | Director | Palo Alto, CA |
| Jeffrey W Bird | Director | Palo Alto, CA |
| Robert Spitale | Director | Aliso Viejo, CA |
| Robert Spitale | Executive Officer | Aliso Viejo, CA |
| Keith W Loebner | Director | Palo Alto, CA |
| Kim W Kamdar | Director | Nissequogue, NY |
Other filings by this issuer (1)
More